SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-002238
Filing Date
2022-08-11
Accepted
2022-08-11 08:16:43
Documents
77
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q syn-20220630x10q.htm   iXBRL 10-Q 1767380
2 EX-10.2 syn-20220630xex10d2.htm EX-10.2 16947
3 EX-31.1 syn-20220630xex31d1.htm EX-31.1 14935
4 EX-32.1 syn-20220630xex32d1.htm EX-32.1 6799
5 GRAPHIC syn-20220630x10q001.jpg GRAPHIC 52096
  Complete submission text file 0001410578-22-002238.txt   7971414

Data Files

Seq Description Document Type Size
6 EX-101.SCH syn-20220630.xsd EX-101.SCH 56484
7 EX-101.CAL syn-20220630_cal.xml EX-101.CAL 48769
8 EX-101.DEF syn-20220630_def.xml EX-101.DEF 248250
9 EX-101.LAB syn-20220630_lab.xml EX-101.LAB 440113
10 EX-101.PRE syn-20220630_pre.xml EX-101.PRE 411857
71 EXTRACTED XBRL INSTANCE DOCUMENT syn-20220630x10q_htm.xml XML 1351808
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12584 | Film No.: 221153811
SIC: 2834 Pharmaceutical Preparations